Sign in

CIK 0001640266

  • Accelerated filer
  • Smaller reporting company

Voyager Therapeutics, Inc.

Sign in to watch
Ticker
VYGR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 857-259-5340
Business address
75 HAYDEN AVENUE, LEXINGTON, MA, 02421
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2015-11-16 LEVIN MARK J Director Conversion · Series A Preferred Stock −45,000,000 0
2015-11-16 Sanofi Former 10% owner Purchase +125,000 $14.00 $1.8M 2,477,941
2015-11-16 Third Rock Ventures III, L.P. 10% owner Conversion +10,588,235 11,061,176
2015-11-16 Third Rock Ventures III, L.P. 10% owner Conversion · Series A Preferred Stock −45,000,000 0
2015-11-16 Hadley Harbor Master Investors (Cayman) L.P. 10% owner Conversion +470,588 470,588
2015-11-16 Hadley Harbor Master Investors (Cayman) L.P. 10% owner Conversion · Series B Convertible Preferred Stock −2,000,000 0
2015-11-10 Sanofi Former 10% owner Conversion +2,352,941 2,352,941
2015-11-10 Sanofi Former 10% owner Conversion · Shares of Series B convertible preferred stock −10,000,000 0

Page 19 of 19 · 368 trades